BRIOTECH IN THE NEWS
SEE BRIOTECH WORLDWIDE
BRIOTECH, ITS LOGOS, LANGUAGE, AND IMAGES ARE TRADEMARKS AND/OR THE COPYRIGHT PROPERTY OF BRIOTECH, INC. AND/OR ITS AFFILIATES. © 2013-2017
BRIOTECH, ITS LOGOS, LANGUAGE, AND IMAGES ARE TRADEMARKS AND/OR THE COPYRIGHT PROPERTY OF BRIOTECH, INC. AND/OR ITS AFFILIATES. © 2013-2017
BRIOTECH   is   proud   to   be   able   to   support   The   Roddenberry Foundation   and   IHS   in   their   work   to   bring   clean   water   to   the residents of Haiti in the aftermath of Hurricane Matthew.
IMMUNE SYSTEM OXIDANT COULD BE KEY TO INACTIVATING PRIONS SEPTEMBER 29, 2016 “BrioHOCl TM  eliminated all  detectable prion-seeding activity” A product that mimics the natural oxidative killing action of human immune cells against bacteria, viruses, and fungi also can inactivate prions and other proteins, some of which are thought to be important in Parkinson’s and Alzheimer’s diseases, according to National Institutes of Health (NIH) researchers. Prions are deadly protein-based pathogens that are extremely difficult to inactivate; recommended decontamination treatments often are dangerous to people or damaging to surfaces, such as those on surgical devices. There are reported cases of a prion disease (Creutzfeldt- Jakob disease, or CJD) being transmitted to patients via contaminated surgical equipment. Scientists at NIH’s National Institute of Allergy and Infectious Diseases (NIAID) first evaluated the product BrioHOCl in laboratory experiments using a prion diagnostic test they developed (RT- QuIC). They then confirmed the results in mice. The scientists determined that BrioHOCl TM   eliminated all detectable prion-seeding activity for CJD, bovine spongiform encephalopathy (BSE, or mad cow disease), chronic wasting disease (a disease primarily found in deer, elk, and moose) and scrapie (a disease of sheep) in brain tissue. They conducted a portion of the study using stainless steel wire as a surrogate for surgical instruments. BrioHOCl TM  had similar effects on two proteins thought to contribute to Parkinson’s disease and Alzheimer’s disease. The Seattle-area company Briotech, Inc., developed BrioHOCl to remove biofilms – clusters of bacteria – from tubing and other surgical equipment. BrioHOCl TM  is a highly purified formulation of hypochlorous acid, which immune cells produce naturally to kill microbes. The NIAID researchers now are interested in discovering how hypochlorous acid inactivates prions, and determining whether they can harness that process to treat or prevent prion and other protein-based diseases. They also plan to evaluate whether BrioHOCl TM  can inactivate prions associated with other tissues, fluids, tools, instruments, and environmental surfaces that may be of concern in medicine, biotechnology, agriculture, food production, and wildlife biology.
INACTIVATION OF PRIONS AND AMYLOID SEEDS WITH HYPHOCHLOROUS ACID SEPTEMBER 29, 2016 “We have tested the anti-prion activity of (BrioHOCl TM ) that poses  no apparent hazard to either users or many surfaces. BrioHOCl TM  can be  applied directly to skin and mucous membranes and has been aerosolized to treat entire rooms without apparent deleterious effects.”
“We    are    dedicated    to    the    goal    of    fundamentally changing     the     discussion     of     health,     healing     and disinfection     in     the     world,     and     to     bring     this     life- changing    product,    as    inexpensively    as    possible,    to developing nations and the people who need it most.”
—BRIOTECH Founders,  Dan Terry and Cynthia Varela
FDA FACILITY REG #3012261723 | EPA #93108
BRIOTECH, ITS LOGOS, LANGUAGE, AND IMAGES ARE TRADEMARKS AND/OR THE COPYRIGHT PROPERTY OF BRIOTECH, INC. AND/OR ITS AFFILIATES. © 2013-2017
BRIOTECH IN THE NEWS
IMMUNE SYSTEM OXIDANT COULD BE KEY TO INACTIVATING PRIONS SEPTEMBER 29, 2016 “BrioHOCl TM  eliminated all  detectable prion-seeding activity” A product that mimics the natural oxidative killing action of human immune cells against bacteria, viruses, and fungi also can inactivate prions and other proteins, some of which are thought to be important in Parkinson’s and Alzheimer’s diseases, according to National Institutes of Health (NIH) researchers. Prions are deadly protein-based pathogens that are extremely difficult to inactivate; recommended decontamination treatments often are dangerous to people or damaging to surfaces, such as those on surgical devices. There are reported cases of a prion disease (Creutzfeldt-Jakob disease, or CJD) being transmitted to patients via contaminated surgical equipment. Scientists at NIH’s National Institute of Allergy and Infectious Diseases (NIAID) first evaluated the product BrioHOCl TM  in laboratory experiments using a prion diagnostic test they developed (RT-QuIC). They then confirmed the results in mice. The scientists determined that BrioHOCl TM   eliminated all detectable prion-seeding activity for CJD, bovine spongiform encephalopathy (BSE, or mad cow disease), chronic wasting disease (a disease primarily found in deer, elk, and moose) and scrapie (a disease of sheep) in brain tissue. They conducted a portion of the study using stainless steel wire as a surrogate for surgical instruments. BrioHOCl TM  had similar effects on two proteins thought to contribute to Parkinson’s disease and Alzheimer’s disease. The Seattle-area company Briotech, Inc., developed BrioHOCl TM  to remove biofilms – clusters of bacteria – from tubing and other surgical equipment. BrioHOCl TM  is a highly purified formulation of hypochlorous acid, which immune cells produce naturally to kill microbes. The NIAID researchers now are interested in discovering how hypochlorous acid inactivates prions, and determining whether they can harness that process to treat or prevent prion and other protein- based diseases. They also plan to evaluate whether BrioHOCl TM  can inactivate prions associated with other tissues, fluids, tools, instruments, and environmental surfaces that may be of concern in medicine, biotechnology, agriculture, food production, and wildlife biology.
INACTIVATION OF PRIONS AND AMYLOID SEEDS WITH HYPHOCHLOROUS ACID SEPTEMBER 29, 2016 “ We have tested the anti-prion activity of (BrioHOCl TM ) that poses  no apparent hazard to either users or many surfaces. BrioHOCl TM  can  be applied directly to skin and mucous membranes and has been aerosolized to treat entire rooms without apparent deleterious effects.”
BRIOTECH     is     proud     to     be     able     to support   The   Roddenberry   Foundation and    IHS    in    their    work    to    bring    clean water   to   the   residents   of   Haiti   in   the aftermath of Hurricane Matthew.
BRIOTECH, ITS LOGOS, LANGUAGE & IMAGES ARE TRADEMARKS & COPYRIGHT PROPERTY OF BRIOTECH, INC. & ITS AFFILIATES. © 2013-2017
CONTACT THE BRIOTECH TEAM
FDA FACILITY REG #3012261723 | EPA #93108